$793 Thousand is the total value of Bronte Capital Management Pty Ltd.'s 27 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 3.6% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $127,229 | -99.9% | 411,877 | -2.9% | 16.05% | +13.8% |
REGN | Sell | REGENERON PHARMACEUTICALS | $102,973 | -99.9% | 142,723 | -3.0% | 12.99% | +2.9% |
GOOGL | Buy | ALPHABET INCcap stk cl a | $97,464 | -99.9% | 1,104,656 | +0.3% | 12.30% | -6.3% |
IBKR | Sell | INTERACTIVE BROKERS GROUP | $60,428 | -99.9% | 835,222 | -3.0% | 7.62% | +11.2% |
V | Sell | VISA INC | $59,683 | -99.9% | 287,271 | -2.9% | 7.53% | +15.0% |
HLF | Sell | HERBALIFE NUTRITION LTD | $39,252 | -99.9% | 2,637,895 | -15.3% | 4.95% | -35.8% |
CTVA | Sell | CORTEVA INC | $36,734 | -99.9% | 624,941 | -26.9% | 4.64% | -23.8% |
HIBB | Buy | HIBBETT INC | $34,664 | -99.8% | 508,122 | +9.6% | 4.37% | +52.0% |
PINS | Sell | PINTEREST INCcl a | $34,283 | -99.9% | 1,411,992 | -2.5% | 4.33% | +3.0% |
IBB | Sell | ISHARES TRishares biotech | $33,822 | -99.9% | 257,615 | -2.1% | 4.27% | +11.4% |
ATVI | Sell | ACTIVISION BLIZZARD INC | $31,570 | -99.9% | 412,409 | -17.6% | 3.98% | -14.1% |
PM | Buy | PHILIP MORRIS INTL INC | $28,427 | -99.8% | 280,876 | +41.0% | 3.59% | +74.2% |
GHC | Sell | GRAHAM HLDGS CO | $15,848 | -99.9% | 26,229 | -8.6% | 2.00% | +4.0% |
GIS | Sell | GENERAL MLS INC | $12,018 | -99.9% | 143,331 | -2.6% | 1.52% | +8.0% |
SQM | Sell | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $11,994 | -99.9% | 150,220 | -1.8% | 1.51% | -12.5% |
STT | Sell | STATE STR CORP | $10,175 | -99.9% | 131,175 | -46.8% | 1.28% | -31.3% |
BK | Sell | BANK NEW YORK MELLON CORP | $9,621 | -99.9% | 211,366 | -40.9% | 1.21% | -29.3% |
GOOG | Buy | ALPHABET INCcap stk cl c | $9,060 | -99.9% | 102,112 | +2.4% | 1.14% | -4.3% |
ALB | Sell | ALBEMARLE CORP | $8,889 | -99.9% | 40,989 | -2.2% | 1.12% | -18.7% |
Sell | BATH & BODY WORKS INC | $8,095 | -99.9% | 192,099 | -2.5% | 1.02% | +27.6% | |
SHC | Sell | SOTERA HEALTH CO | $5,652 | -99.9% | 678,512 | -17.7% | 0.71% | +1.9% |
MDLZ | Sell | MONDELEZ INTL INCcl a | $4,857 | -99.9% | 72,873 | -3.0% | 0.61% | +19.5% |
NPO | Sell | ENPRO INDS INC | $3,259 | -99.9% | 29,988 | -2.0% | 0.41% | +26.9% |
MO | Sell | ALTRIA GROUP INC | $2,993 | -100.0% | 65,483 | -67.3% | 0.38% | -62.5% |
Buy | RISKIFIED LTD | $2,246 | -99.9% | 486,255 | +9.6% | 0.28% | +29.8% | |
BNTX | Sell | BIONTECH SEsponsored ads | $1,014 | -99.9% | 6,751 | -2.8% | 0.13% | +9.4% |
DBTX | Sell | DECIBEL THERAPEUTICS INC | $327 | -99.9% | 159,405 | -2.5% | 0.04% | -41.4% |
AVLR | Exit | AVALARA INC | $0 | – | -31,845 | -100.0% | -0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
CORTEVA NC | 17 | Q3 2023 | 6.2% |
GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
SCHEDULE 13G | 2024-02-13 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-03 |
13F-HR/A | 2022-08-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.